WASHINGTON–The National Consumers League (NCL) wants the Food and Drug Administration to keep Clarinex as a prescription-only product. The medication reached the market in January.
Earlier this yea…
KENILWORTH, N.J. — Schering-Plough Corp. bas received Food and Drug Administration approval of Clarinex (desloratadine) for the treatment of seasonal allergic rhinitis (SAR).
The product builds upon the company’s heritage as a discoverer and developer of allergy and respiratory products as demonstrated by the success of its Claritin collection of nonsedating antihistamines and by Nasonex, a once-daily nasal st…
Cima Labs Inc. says OraSolv, its orally disintegrating drug delivery technology, will be incorporated in a version of Schering-Plough Corp.’s Clarinex Reditabs. Schering recently received FDA approval to market the product. The tablets disintegrate on the tongue without chewing or the need forwater.
Related Results
Cl…
